Each tablet contains 80 mg Gliclazide.
GLICLAZIDE is a sulphonylurea hypoglycemic agent with actions and uses similar to chlorpropamide. It is readily absorbed in the gastrointestinal tract and extensively metabolised in the liver. Both unchanged drug and metabolites are excreted in the urine. Its duration of action is 12 hours or more.
Oral antidiabetic agent for Type 2 Diabetes Mellitus (NIDDM).
Initial Dose: 1 tablet per day with breakfast.
Maintenance Dose: 2 tablets per day in divided doses with morning and evening meals or as prescribed by the physician.
Severe Dose: 3-4 tablets per day in divided doses or as prescribed by the physician.
GLICLAZIDE should not be used in insulin-dependent diabetes mellitus. It is contraindicated in patients with ketoacidosis and in those with severe infection, stress or trauma.
GLICLAZIDE should not be given to patients with severe impairment of renal, hepatic or thyroid function.
Gastrointestinal disturbances e.g., nausea, vomiting, heartburn, anorexia, constipation, and diarrhea are dose-dependent effects. Skin rashes and pruritus may occasionally occur.
Store at temperatures not exceeding 30°C. Protect from light and moisture.
A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Gluconil tab 80 mg
100's (P703.08/pack)